Welcome back to another AJMC Stakeholder Summit series. In "Vitiligo Prevalence and Why It Isn't Cosmetic," moderator Susan ...
The AAO 2026 annual meeting, held in New Orleans, Louisiana, from October 10 to October 12, 2026, was a weekend that provided ...
Experts at CHEST 2026 urge pulmonologists to keep lung cancer in mind for younger patients who never smoked, to order ...
Intensive blood pressure (BP) lowering reduced the risk of major cardiovascular events by 15% for every 10-mm Hg reduction in ...
The FDA approved phentolamine ophthalmic solution 0.75% (Ryzumvi; Viatris) for the treatment of presbyopia in adults, giving ...
Pulmonologists play a key role in comprehensive biomarker testing, helping more patients with lung cancer access precise ...
Limited access to care means safety-net ICUs see advanced disease and poorer outcomes, while bias and social media add new ...
FDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase ...
OneOncology's Larry Bilbrey explains how to guide practices on AI without endorsing products and why technology gaps outweigh ...
Nearly 3 in 4 adults undergoing metabolic bariatric surgery (MBS) at 4 international centers met criteria for clinical ...
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
Recent ENDURANCE data support 2-year lenalidomide maintenance in standard-risk multiple myeloma and individualize when to stop.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results